65 related articles for article (PubMed ID: 29984612)
1. Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer.
Bogani G; Ditto A; Leone Roberti Maggiore U; Scaffa C; Mosca L; Chiappa V; Martinelli F; Lorusso D; Raspagliesi F
Tumori; 2019 Feb; 105(1):92-97. PubMed ID: 29984612
[TBL] [Abstract][Full Text] [Related]
2. Potential utility of pretreatment serum miRNAs for optimal treatment selection in advanced high-grade serous ovarian cancer.
Uehara T; Matsuzaki J; Yoshida H; Ogawa Y; Miura J; Fujimiya H; Yamamoto Y; Kawauchi J; Takizawa S; Yonemori K; Sakamoto H; Kato K; Ishikawa M; Ochiya T
Jpn J Clin Oncol; 2024 Apr; ():. PubMed ID: 38651188
[TBL] [Abstract][Full Text] [Related]
3. Advanced ovarian yolk sac tumor: upfront surgery or neoadjuvant chemotherapy followed by interval debulking?
Zhang X; Yang J; Xiang Y; Pan L; Wu M; Cao D; Yang J
Int J Gynecol Cancer; 2023 Sep; ():. PubMed ID: 37696647
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis.
Kanno M; Yunokawa M; Kurihara N; Aoki Y; Omi M; Tanigawa T; Kanao H
J Gynecol Oncol; 2023 Nov; 34(6):e77. PubMed ID: 37477100
[TBL] [Abstract][Full Text] [Related]
5. MIRRORS: a prospective cohort study assessing the feasibility of robotic interval debulking surgery for advanced-stage ovarian cancer.
Uwins C; Assalaarachchi H; Bennett K; Read J; Tailor A; Crawshaw J; Chatterjee J; Ellis P; Skene SS; Michael A; Butler-Manuel S
Int J Gynecol Cancer; 2024 Apr; ():. PubMed ID: 38561194
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review.
Huang AB; Wu J; Chen L; Albright BB; Previs RA; Moss HA; Davidson BA; Havrilesky LJ; Melamed A; Wright JD
Gynecol Oncol Rep; 2021 Nov; 38():100887. PubMed ID: 34820496
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Chemotherapy and Surgery for Cervical Cancer, Timing of Surgery for Esophageal Cancer, Endometrial Cancer Molecular Classification, Vestibular Schwannoma, and Breast Boost Techniques.
Dover L; Dulaney C
Pract Radiat Oncol; 2024; 14(1):1-5. PubMed ID: 38182302
[No Abstract] [Full Text] [Related]
8. Adding immunotherapy to chemotherapy improves survival for endometrial cancer patients.
Fillon M
CA Cancer J Clin; 2023; 73(5):445-447. PubMed ID: 37665330
[No Abstract] [Full Text] [Related]
9. Correction: Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
Int J Gynecol Cancer; 2023 Oct; 33(10):1673. PubMed ID: 37783483
[No Abstract] [Full Text] [Related]
10. Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer.
de Lange NM; Ezendam NPM; Kwon JS; Vandenput I; Mirchandani D; Amant F; van der Putten LJM; Pijnenborg JMA
Curr Oncol; 2019 Apr; 26(2):e226-e232. PubMed ID: 31043831
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy in patients with advanced endometrial cancer.
Khouri OR; Frey MK; Musa F; Muggia F; Lee J; Boyd L; Curtin JP; Pothuri B
Cancer Chemother Pharmacol; 2019 Aug; 84(2):281-285. PubMed ID: 30980132
[TBL] [Abstract][Full Text] [Related]
12. Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer.
Tobias CJ; Chen L; Melamed A; St Clair C; Khoury-Collado F; Tergas AI; Hou JY; Hur C; Ananth CV; Neugut AI; Hershman DL; Wright JD
JAMA Netw Open; 2020 Dec; 3(12):e2028612. PubMed ID: 33295973
[TBL] [Abstract][Full Text] [Related]
13. The use of neoadjuvant chemotherapy in advanced endometrial cancer.
Philp L; Kanbergs A; Laurent JS; Growdon WB; Feltmate C; Goodman A
Gynecol Oncol Rep; 2021 May; 36():100725. PubMed ID: 33644284
[TBL] [Abstract][Full Text] [Related]
14. JGOG2046: a feasibility study of neoadjuvant chemotherapy followed by debulking surgery for clinically diagnosed FIGO stage IVb endometrial cancer.
Nakanishi T; Saito T; Aoki D; Watanabe Y; Ushijima K; Takano M; Sugiyama T; Yaegashi N; Takehara K
Int J Clin Oncol; 2023 Mar; 28(3):436-444. PubMed ID: 36729215
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study.
Lim H; Bang SH; Kim Y; Cho SH; Shin W; Kim SI; Kim TH; Suh DH; Lim MC; Kim JW
BMC Cancer; 2022 Jun; 22(1):703. PubMed ID: 35761211
[TBL] [Abstract][Full Text] [Related]
16. Advanced stage (IIIC/IV) endometrial cancer: Role of cytoreduction and determinants of survival.
Rajkumar S; Nath R; Lane G; Mehra G; Begum S; Sayasneh A
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():26-31. PubMed ID: 30639953
[TBL] [Abstract][Full Text] [Related]
17. Single Institute Experience with Neo-Adjuvant Chemotherapy and Interval Debulking Surgery in Advanced Endometrial Cancer.
Varshney J; Debnath S; Sharma A; Rawal S; Jain V
Indian J Surg Oncol; 2023 Dec; 14(4):800-808. PubMed ID: 38187853
[TBL] [Abstract][Full Text] [Related]
18. Optimal Management for Stage IVB Endometrial Cancer: A Systematic Review.
Capozzi VA; Scarpelli E; De Finis A; Rotondella I; Scebba D; Gallinelli A; Montrucchio C; Martignon G; Leotta M; Ghi T; Berretta R
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958299
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
